Preliminary report of Italian-Scandinavian Sarcoma Group (ISG-SSG) IV protocol: high risk Ewing's sarcoma, Italian experience

被引：0
|
作者：
Tienghi, A
Giovanis, P
Del Duca, M
del Prever, AB
Fagioli, F
Luskch, R
Casanova, M
Pession, A
Rosito, P
Mercuri, M
Picci, P
Bacci, G
Barbieri, E
Marangolo, M
机构：
来源：
BONE MARROW TRANSPLANTATION | 2001年 / 27卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S33 / S33
页数：1
相关论文
共 50 条
  • [41] ABCB1/P-glycoprotein (Pgp) expression as stratification factor for treatment of patients with non metastatic extremity high grade osteosarcoma: An Italian Sarcoma Group (ISG) multicentric prospective trial (ISG/OS-2)
    Palmerini, E.
    Meazza, C.
    Tamburini, A.
    Bisogno, G.
    Ferraresi, V.
    Asaftei, S.
    Milano, G. M.
    Coccoli, L.
    Manzitti, C.
    Luksch, R.
    Donati, D. M.
    Serra, M.
    Bertulli, R.
    Gambarotti, M.
    Favre, C.
    Longhi, A.
    Casali, P. G.
    Picci, P.
    Fagioli, F.
    Ferrari, S.
    [J]. ANNALS OF ONCOLOGY, 2020, 31 : S976 - S976
  • [42] Megatherapy and hematopoetic stem cell rescue In the primary bone high-risk and inoperable Pnet/Ewing's sarcoma. Ten Years experience
    Malis, J
    Kabickova, E
    Valkova, J
    Koutecky, J
    Mracek, J
    Malinova, B
    [J]. BONE MARROW TRANSPLANTATION, 2002, 29 : S208 - S209
  • [43] Short, full-dose adjuvant chemotherapy (CT) in high-risk adult soft tissue sarcomas (STS): long-term follow-up of a randomized clinical trial from the Italian Sarcoma Group and the Spanish Sarcoma Group
    Gronchi, A.
    Stacchiotti, S.
    Verderio, P.
    Ferrari, S.
    Broto, J. Martin
    Lopez-Pousa, A.
    Llombart-Bosch, A.
    Tos, A. P. Dei
    Collini, P.
    Cruz Jurado, J.
    De Paoli, A.
    Donati, D. M.
    Poveda, A.
    Quagliuolo, V.
    Comandone, A.
    Grignani, G.
    Morosi, C.
    Messina, A.
    De Sanctis, R.
    Bottelli, S.
    Palassini, E.
    Casali, P. G.
    Picci, Piero
    [J]. ANNALS OF ONCOLOGY, 2016, 27 (12) : 2283 - 2288
  • [44] Efficacy of haematopoietic progenitor cells mobilization and results of high-dose chemotherapy followed by autologous transplantation in children with high-risk Ewing's sarcoma - single center experience
    Gozdzik, Jolanta
    Skoczen, Szymon
    Krasowska-Kwiecien, Aleksandra
    Wedrychowicz, Anna
    Wiecha, Oktawiusz
    Czogala, Wojciech
    Jarocha, Danuta
    Majka, Marcin
    [J]. BONE MARROW TRANSPLANTATION, 2008, 42 : S118 - S118
  • [45] Short, full-dose adjuvant chemotherapy (CT) in high-risk adult soft tissue sarcomas (STS): Long-term follow-up of a randomized clinical trial from the Italian Sarcoma Group and the Spanish Sarcoma Group.
    Palassini, Elena
    Ferrari, Stefano
    Broto, Javier Martin
    Verderio, Paolo
    Lopez-Pousa, Antonio
    Buonadonna, Angela
    Miceli, Rosalba
    Stacchiotti, Silvia
    Dei Tos, Angelo Paolo
    De Paoli, Antonino
    Donati, Davide Maria
    Poveda, Andres
    Quagliuolo, Vittorio
    Comandone, Alessandro
    Bottelli, Stefano
    Picci, Piero
    Casali, Paolo Giovanni
    Gronchi, Alessandro
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [46] High dose Holmium-166 DOTMP - A novel treatment for children and young adults with metastatic Ewing's sarcoma: Preliminary experience on pharmacokinetics, biodistribution and radiation absorbed dose estimation.
    Rajendran, JG
    Hawkins, DS
    Durack, LD
    Vernon, C
    Eary, JF
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2003, 44 (05) : 412P - 412P
  • [47] Phase 2 study for nonmetastatic extremity high-grade osteosarcoma in pediatric and adolescent and young adult patients with a risk-adapted strategy based on ABCB1/P-glycoprotein expression: An Italian Sarcoma Group trial (ISG/OS-2)
    Palmerini, Emanuela
    Meazza, Cristina
    Tamburini, Angela
    Bisogno, Gianni
    Ferraresi, Virginia
    Asaftei, Sebastian D.
    Milano, Giuseppe M.
    Coccoli, Luca
    Manzitti, Carla
    Luksch, Roberto
    Serra, Massimo
    Gambarotti, Marco
    Donati, Davide M.
    Scotlandi, Katia
    Bertulli, Rossella
    Favre, Claudio
    Longhi, Alessandra
    Abate, Massimo E.
    Perrotta, Silverio
    Mascarin, Maurizio
    D'Angelo, Paolo
    Cesari, Marilena
    Staals, Eric L.
    Marchesi, Emanuela
    Carretta, Elisa
    Ibrahim, Toni
    Casali, Paolo G.
    Picci, Piero
    Fagioli, Franca
    Ferrari, Stefano
    [J]. CANCER, 2022, 128 (10) : 1958 - 1966
  • [48] High histologic and overall response to dose intensification of ifosfamide, carboplatin, and etoposide with cyclophosphamide, doxorubicin, and vincristine in patients with high-risk Ewing sarcoma family tumors - The Bambino Gesu Children's Hospital experience
    Milano, GM
    Cozza, R
    Ilari, I
    De Sio, L
    Boldrini, R
    Jenkner, A
    De Ioris, M
    Inserra, A
    Dominici, C
    Donfrancesco, A
    [J]. CANCER, 2006, 106 (08) : 1838 - 1845
  • [49] Pooled analysis of phase II window studies in children with contemporary high-risk metastatic rhabdomyosarcoma: A report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group
    Lager, Joanne J.
    Lyden, Elizabeth R.
    Anderson, James R.
    Pappo, Alberto S.
    Meyer, William H.
    Breitfeld, Philip P.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (21) : 3415 - 3422
  • [50] Assessment of response to induction therapy and its influence on 5-year failure-free survival in group III rhabdomyosarcoma: The intergroup rhabdomyosarcoma study-IV experience - A report from the soft tissue sarcoma committee of the children's oncology group
    Burke, Megan
    Anderson, James R.
    Kao, Simon C.
    Rodeberg, David
    Qualman, Stephen J.
    Wolden, Suzanne L.
    Meyer, William H.
    Breitfeld, Philip P.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (31) : 4909 - 4913
12345